円
2233.00
Apr 18
Business Description
Fuso Pharmaceutical Industries Ltd
NAICS : 325411
SIC : 2833
ISIN : JP3823600006
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | 6.94 | |||||
Interest Coverage | 12.48 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 1.61 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | 10 | |||||
3-Year EPS without NRI Growth Rate | 31.1 | |||||
3-Year FCF Growth Rate | -26.5 | |||||
3-Year Book Growth Rate | 3.4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.09 | |||||
9-Day RSI | 53.19 | |||||
14-Day RSI | 51.2 | |||||
6-1 Month Momentum % | 19.1 | |||||
12-1 Month Momentum % | 13.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.52 | |||||
Quick Ratio | 1.09 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 113.88 | |||||
Days Sales Outstanding | 157.77 | |||||
Days Payable | 63.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.2 | |||||
Dividend Payout Ratio | 0.46 | |||||
3-Year Dividend Growth Rate | 5.3 | |||||
Forward Dividend Yield % | 3.2 | |||||
5-Year Yield-on-Cost % | 2.57 | |||||
Shareholder Yield % | -0.62 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.29 | |||||
Operating Margin % | 3.82 | |||||
Net Margin % | 2.45 | |||||
FCF Margin % | 2.34 | |||||
ROE % | 3.74 | |||||
ROA % | 1.79 | |||||
ROIC % | 2.48 | |||||
ROC (Joel Greenblatt) % | 5.39 | |||||
ROCE % | 4.57 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.45 | |||||
PE Ratio without NRI | 13.57 | |||||
Shiller PE Ratio | 18.64 | |||||
PEG Ratio | 1.58 | |||||
PS Ratio | 0.36 | |||||
PB Ratio | 0.52 | |||||
Price-to-Tangible-Book | 0.53 | |||||
Price-to-Free-Cash-Flow | 15.31 | |||||
Price-to-Operating-Cash-Flow | 6.86 | |||||
EV-to-EBIT | 12.87 | |||||
EV-to-EBITDA | 12.87 | |||||
EV-to-Revenue | 0.49 | |||||
EV-to-FCF | 20.75 | |||||
Price-to-Projected-FCF | 0.5 | |||||
Price-to-Median-PS-Value | 0.7 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.44 | |||||
Price-to-Graham-Number | 0.57 | |||||
Price-to-Net-Current-Asset-Value | 3.3 | |||||
Earnings Yield (Greenblatt) % | 7.76 | |||||
FCF Yield % | 6.77 | |||||
Forward Rate of Return (Yacktman) % | 15.35 |